Mehmet Oğuzhan Polat

Dr. Mehmet Oğuzhan Polat

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
OAOrhan Aslan
Orhan Aslan
MPMehmet Oğuzhan Polat
Mehmet Oğuzhan Polat
APAşkın Kadir Perçem
Aşkın Kadir Perçem
RTRamazan Topcu
Ramazan Topcu
MYMahmut Arif Yüksek
Mahmut Arif Yüksek
MŞMustafa Şahin
Mustafa Şahin
Background: Risk stratification after colorectal cancer surgery remains challenging. We evaluated whether a perioperative ratio combining immediate postoperative lactate with preoperative albumin is associated with in-hospital mortality after elective colorectal resection. Methods: In this single-center retrospective cohort, 282 patients underwent open elective colorectal resection. The perioperative lactate-to-albumin ratio (LAR) was calculated as arterial lactate (mmol/L) divided by serum albumin (g/dL), and discrimination was assessed by receiver operating characteristic (ROC) analysis with age-adjusted association by Firth’s penalized logistic regression and fixed-model bootstrap validation. Results: Seventeen patients (6.0%) died in hospital, and mortality rose across LAR tertiles (2.1%, 5.3%, and 10.6%; p = 0.014). LAR showed moderate discrimination (AUC 0.73; 95% CI 0.58–0.87; optimism-corrected AUC 0.78), with no evidence of better discrimination than lactate or albumin alone. At the Youden threshold of 0.555, sensitivity was 76.5% and specificity 61.1%. The age-adjusted Firth odds ratio was 1.19 per 0.1-unit increase (95% CI 1.09–1.29). Conclusions: The perioperative lactate-to-albumin ratio was associated with in-hospital mortality after age adjustment in this single-center cohort. Given the small number of deaths and absence of external validation, LAR should be regarded as a candidate marker requiring prospective multicenter validation before clinical application.

25 October 2026 in Journal of Health Sciences and Medicine
Verified
Journal Article
Open access
OAOrhan Aslan
Orhan Aslan
RTRamazan Topcu
Ramazan Topcu
MYMahmut Arif Yüksek
Mahmut Arif Yüksek
MPMehmet Oğuzhan Polat
Mehmet Oğuzhan Polat
APAşkın Kadir Perçem
Aşkın Kadir Perçem
HŞHavva Hande Keser Şahin
Havva Hande Keser Şahin
Aims: Differentiating between benign and malignant thyroid nodules preoperatively is of critical clinical importance. This study aims to evaluate the effectiveness of the Systemic Immune-Inflammation Index (SII) and the Prognostic Nutritional Index (PNI), derived from routine laboratory tests, in the differential diagnosis of thyroid nodules.Methods: A retrospective analysis was conducted on 345 patients (215 benign, 130 malignant) who underwent surgery at a university hospital’s general surgery clinic between 2015 and 2025 and had definitive histopathological diagnoses. SII and PNI values were calculated from preoperative blood parameters. Group comparisons, bias-reduced logistic regression, and receiver operating characteristic (ROC) analysis were utilized to assess diagnostic performance.Results: No, statistically significant differences were found between the benign and malignant groups regarding SII (p=0.728) or PNI (p=0.299). After adjusting for age, gender, comorbidities, and histologic thyroiditis in logistic regression models, Neither Index showed a significant association with malignancy. ROC analysis demonstrated near-chance discriminatory ability for both SII (AUC: 0.511) and PNI (AUC: 0.467), indicating that these markers lack sufficient diagnostic accuracy.Conclusion: In this surgical cohort, preoperative SII and PNI showed no detectable stand-alone discrimination between benign and malignant thyroid pathology; whether they add value to ultrasonography and cytology remains to be tested.